EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

EEDGAR/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice. EDGAR is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. EDGAR/calls is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›SNYR

SNYR

Synergy CHC Corp.

Next earnings Aug 12, 2026 · consensus $0.09 EPS, $11.7M rev

Last earnings -8.3% on 2026-05-14

Avoid
$0.21
▲ +3.05%
$0.21▼ -91.86%
over 1Y
L $0.19EODHDH $3.97
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+3.1%
1W-6.6%
1M-17.0%
3M-82.7%
YTD-88.9%
1Y-91.9%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Avoid
Quality
F
Valuation
Fair value
Filings
Flagged
Avoid
Conviction
Horizon
Medium (3–12mo)
Street · 8 analysts
Buy

Conservative balance sheet (liabilities/equity -1.44x); but revenue fell -12.8% YoY.

Revenue (FY2025) $30.4M · FY2025

Synergy CHC Corp. shows $30.4M in FY2025 revenue (-12.8% YoY), a -40.6% net margin.

Financials · annual, by fiscal year

Line itemFY18FY19FY23FY24FY25
Revenue$33.8M—$42.8M$34.8M$30.4M
Gross profit$22.8M$20.2M$32.1M$23.6M$20.3M
Operating income-$4.92M-$7.96M$10.8M$5.80M-$8.46M
Net income-$6.16M-$9.21M$6.34M$2.12M-$12.3M
Diluted EPS-$0.07-$0.10$0.86$0.28-$1.27
Net margin-18.2%—14.8%6.1%-40.6%

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$28.8M
EV / EBITDA—
EV / Sales0.9
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-521.9%
FCF yield-114.8%

Quality & risk

ROIC (est.)—
Free cash flow-$2.71M
Total debt$29.1M
Net cash-$26.4M
Altman Z-Score-7.28 distress
Piotroski F-Score3/9

Capital returns

Buyback yield—
Dividend yield (est.)49.6%
Shareholder yield49.6%
Shares Δ YoY+29.2%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Red flag in recent filings — delisting notice (2026-05-18). Worth a closer look.
  1. 8-K Delisting notice2026-05-18
  2. S-1 Securities registration2026-05-15
  3. 8-K Earnings results2026-05-14
  4. 10-Q Quarterly report2026-05-14
  5. 8-K Material agreement2026-05-11
  6. DEF 14A Proxy statement2026-04-30
  7. 10-K Annual report2026-04-01
  8. NT 10-K Late filing notice2026-04-01
  9. 8-K Material agreement2026-03-25

Recent filings

all on EDGAR ↗
EFFECTFiling2026-05-22open ↗8-KPeriod ending 2026-05-152026-05-18open ↗S-1Filing2026-05-15open ↗8-KPeriod ending 2026-05-142026-05-14open ↗10-QPeriod ending 2026-03-312026-05-14open ↗8-KPeriod ending 2026-05-082026-05-11open ↗ARSPeriod ending 2025-12-312026-04-30open ↗DEFA14AFiling2026-04-30open ↗DEF 14APeriod ending 2026-06-292026-04-30open ↗4Period ending 2026-04-212026-04-24open ↗4Period ending 2026-04-212026-04-23open ↗PRE 14APeriod ending 2026-04-172026-04-17open ↗

Quality score

F
ValueGrowthProfitHealthMom.
ValueA+
GrowthF
ProfitabilityF
Financial healthF
Momentum—
  • ✗Revenue growing year-over-year
  • ✗Profitable (positive net income)
  • ✗Net margin above 10%
  • ✓Liabilities below 2× equity
Revenue
$30.4M
-12.8% YoY
Net margin
-40.6%
ROE
—
P/E
—

SEC fundamentals · FY 2025

'18'19'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$30.4M-12.8%
Net income-$12.3M-680.8%
Gross profit$20.3M-14.1%
Operating income-$8.46M-245.8%
Diluted EPS-$1.27-553.6%
Cash & equivalents$2.62M+281.2%
Total assets$10.2M-37.8%
Total liabilities$33.3M+1.0%
Stockholders' equity-$23.1M-39.1%
Gross: 66.8%Op.: -27.8%L/E: -1.44x

Frequently asked

Is Synergy CHC Corp. (SNYR) a buy?
SNYR currently carries a Avoid rating with 4/5 conviction, derived from its latest SEC filings. Conservative balance sheet (liabilities/equity -1.44x); but revenue fell -12.8% YoY.
What is Synergy CHC Corp.'s quality score?
SNYR scores 35.88235294117647/100 (grade F) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001562733, latest 10-Q filed 2026-05-14) · EODHD · as of 6/27/2026, 5:25:08 PM.

Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC
2026-04-21
Kaushal Nitin
Director
Award306K
2026-04-21
Thompson Teresa Brigid
Director
Award25.8K
2025-07-30
Ross Jack
CEO and Chairman
Buy100.00 @ $3.69$369.00
2025-07-29
Ross Jack
CEO and Chairman
Buy250.00 @ $3.66$915.00
2025-07-25
Ross Jack
CEO and Chairman
Buy350.00 @ $3.90$1.36K
2025-07-24
Ross Jack
CEO and Chairman
Buy300.00 @ $3.83$1.15K
2025-07-22
Ross Jack
CEO and Chairman
Buy300.00 @ $3.54$1.06K
2025-07-11
Ross Jack
CEO and Chairman
Buy750.00 @ $3.20$2.40K
2025-07-10
Ross Jack
CEO and Chairman
Buy1.40K @ $3.19$4.47K
2025-07-09
Ross Jack
CEO and Chairman
Buy400.00 @ $3.15$1.26K
2025-07-08
Ross Jack
CEO and Chairman
Buy800.00 @ $3.36$2.69K
2025-07-07
Ross Jack
CEO and Chairman
Buy700.00 @ $3.26$2.28K

Earnings history

beat/miss · move
2026-05-14Miss -744.3% est▼ -8.33%8-K ↗
2025-11-13Miss -2.0% est▼ -6.37%8-K ↗
2025-08-14Beat +108.3% est▼ -8.03%8-K ↗
2025-05-15—▲ +10.31%8-K ↗
2025-03-31—▼ -18.97%8-K ↗
2024-12-06—▼ -0.54%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Recent news

market news →
Synergy CHC Corp. (SNYR) Reports Q1 Loss, Misses Revenue EstimatesBullish
finance.yahoo.com· 2026-05-14
PACS Group, Inc. (PACS) Q1 Earnings and Revenues Surpass EstimatesBullish
finance.yahoo.com· 2026-05-11
Synergy CHC Corp. Q4 2025 Earnings Call SummaryBearish
finance.yahoo.com· 2026-04-02
Synergy CHC Corp. Announces Date Change of Fourth Quarter and Full Year 2025 Earnings and Conference CallBullish
globenewswire.com· 2026-03-30
HealthEquity (HQY) Beats Q4 Earnings and Revenue EstimatesBullish
finance.yahoo.com· 2026-03-17
Synergy CHC Corp. (NASDAQ: SNYR) Appoints Pedro Colmenares as Director of Sales & Marketing for Mexico & Latin AmericaBullish
finance.yahoo.com· 2025-12-16

Vs tracked universe

compare →

1043 tracked peers · median

EDGAR Score36 vs 67
Revenue growth-12.8% vs 7.1%
Net margin-40.6% vs 10.5%
Return on equity— vs 12.3%
P/E— vs 25.5

News sentiment

EODHD · 2d
Bullish
+0.18
vs typical · 2 articles
↑ improving

Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.